Zuo SJ - Search Results

1

Structural modification and antihypertensive activity study of formononetin derivatives.

Zuo SJ, Ma DL, Li J, Guo QH, Zhou L. Zuo SJ, et al. J Asian Nat Prod Res. 2022 Sep;24(9):839-848. doi: 10.1080/10286020.2021.2005588. Epub 2021 Nov 29. J Asian Nat Prod Res. 2022. PMID: 34844472

2

Magnesium Isoglycyrrhizinate Alleviates Arsenic Trioxide-Induced Cardiotoxicity: Contribution of Nrf2 and TLR4/NF-κB Signaling Pathway.

Zheng B, Yang Y, Li J, Li J, Zuo S, Chu X, Xu S, Ma D, Chu L. Zheng B, et al. Drug Des Devel Ther. 2021 Feb 12;15:543-556. doi: 10.2147/DDDT.S296405. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 33603344 Free PMC article.

3

Protective effects of 18β-Glycyrrhetinic acid against myocardial infarction: Involvement of PI3K/Akt pathway activation and inhibiting Ca²⁺ influx via L-type Ca²⁺ channels.

Chu S, Wang W, Zhang N, Liu T, Li J, Chu X, Zuo S, Ma Z, Ma D, Chu L. Chu S, et al. Food Sci Nutr. 2021 Oct 24;9(12):6831-6843. doi: 10.1002/fsn3.2639. eCollection 2021 Dec. Food Sci Nutr. 2021. PMID: 34925811 Free PMC article.

4

Liquiritigenin protects against myocardial ischemic by inhibiting oxidative stress, apoptosis, and L-type Ca²⁺ channels.

Zhang M, Qi J, He Q, Ma D, Li J, Chu X, Zuo S, Zhang Y, Li L, Chu L. Zhang M, et al. Phytother Res. 2022 Sep;36(9):3619-3631. doi: 10.1002/ptr.7528. Epub 2022 Jun 23. Phytother Res. 2022. PMID: 35747908

5

Combination of 4-anilinoquinazoline, arylurea and tertiary amine moiety to discover novel anticancer agents.

Zuo SJ, Zhang S, Mao S, Xie XX, Xiao X, Xin MH, Xuan W, He YY, Cao YX, Zhang SQ. Zuo SJ, et al. Bioorg Med Chem. 2016 Jan 15;24(2):179-90. doi: 10.1016/j.bmc.2015.12.001. Epub 2015 Dec 2. Bioorg Med Chem. 2016. PMID: 26706113

6

Discovery of novel 3-benzylquinazolin-4(3H)-ones as potent vasodilative agents.

Zuo SJ, Li S, Yu RH, Zheng GX, Cao YX, Zhang SQ. Zuo SJ, et al. Bioorg Med Chem Lett. 2014 Dec 15;24(24):5597-5601. doi: 10.1016/j.bmcl.2014.10.092. Epub 2014 Nov 3. Bioorg Med Chem Lett. 2014. PMID: 25466182

7

TRIM21 promotes tumor progression and cancer stemness in cervical squamous cell carcinoma.

Yang Y, Zuo S, Li W, Di M, Liu J, Chai J, Wang J, Yuan Y, Li M, Jia Q. Yang Y, et al. Pathol Res Pract. 2023 Aug;248:154710. doi: 10.1016/j.prp.2023.154710. Epub 2023 Jul 23. Pathol Res Pract. 2023. PMID: 37494805

8

Quantitative analysis and pharmacokinetic study of a novel diarylurea EGFR inhibitor (ZCJ14) in rat plasma using a validated LC-MS/MS method.

Zuo SJ, Cheng XL, Liu DZ, Feng WY, Cao YX, Zhang SQ. Zuo SJ, et al. Acta Pharm. 2020 Dec 31;71(3):415-428. doi: 10.2478/acph-2021-0024. Print 2021 Sep 1. Acta Pharm. 2020. PMID: 36654089 Free article.

9

Novel compound ZCJ14, a gefitinib analog, exhibited prominent anti-cancer effect among several cancer cell lines.

Wang J, Yan PP, Wang HY, Zuo SJ, Zhang SQ, Cao YX, Cao L. Wang J, et al. Among authors: zuo sj. Life Sci. 2022 Oct 15;307:120875. doi: 10.1016/j.lfs.2022.120875. Epub 2022 Aug 10. Life Sci. 2022. PMID: 35963298

10

FBXO39 predicts poor prognosis and correlates with tumor progression in cervical squamous cell carcinoma.

Yang Y, Zhao Y, Sun G, Zuo S, Chai J, Xu T, Liu J, Li L, Song J, Qian S, Kang Y, Sui F, Li M, Jia Q. Yang Y, et al. Pathol Res Pract. 2022 Oct;238:154090. doi: 10.1016/j.prp.2022.154090. Epub 2022 Aug 28. Pathol Res Pract. 2022. PMID: 36049441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters